Glenmark Topiramate Tablets — Class III drug recall D-331-2013
Terminated recall by Glenmark Generics Inc., USA, reported 2013-05-22, distributed nationwide. Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. descr
| Recall number | D-331-2013 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glenmark Generics Inc., USA, Mahwah, NJ, United States |
| Recall initiated | 2013-04-05 |
| Classified | 2013-05-16 |
| Reported by FDA | 2013-05-22 |
| Terminated | 2014-10-09 |
| Distributed | Nationwide (US) |
| Quantity | 9,624 bottles |
| Reason classes | chemical contamination |
| NDC | 68462-0108, 68462-0108-05, 68462-0108-10, 68462-0108-60, 68462-0109, 68462-0109-05, 68462-0109-10, 68462-0109-60, 68462-0110, 68462-0110-05, 68462-0110-10, 68462-0110-60, 68462-0153, 68462-0153-05, 68462-0153-10, 68462-0153-60 |
| Lot numbers | 02123782, 11/14 |
Product
Glenmark Topiramate Tablets, 200 mg, 60-count bottle, (NDC 68462-110-60), Rx only, Manufactured by Glenmark Generics Ltd.Colvale- Bardez Ltd 403513, India Manufactured for : Glenmark Generics USA Mahwah, NJ 07430
Reason for recall
Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-331-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.